Voluntary recall issued for MarcasUSA contaminated OTC skin protectant

fda
(U.S. Food and Drug Administration)

MarcasUSA and Industria Farmacéutica Andromaco have issued a voluntary recall for four lots of Pasta De Lassar Andromaco Skin Protectant, an OTC skin product that was found to be contaminated.

In the recall notice posted by the FDA, an analysis by the regulatory agency of the 25% zinc oxide product found high levels of yeast, mold, and bacteria. Although the contaminated lot that was tested was not sold in the U.S., the discovery resulted in the recall of four lots that were distributed in the country.

To date, the company said it has not received any reports of adverse effects from use of the product.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Pasta de Lassar Andromaco is used for the treatment and prevention of diaper rash and other minor skin irritations.

Suggested Articles

Online pharmacy Valisure has criticized the FDA for what it deems as irrational standards in the levels of suspected carcinogens in the drug supply.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Catalent is buying a site in Italy from Bristol-Myers Squibb that handles biologics along with old-school solid dose production.